Allergan Academic Partnership.
- Published in:
- Optometric Education, 2015, v. 41, n. 1, p. 18
- Publication type:
- Article
Works matching DE "ALLERGAN PLC"
Results: 25
1
2
A237 IMPROVEMENT IN ABDOMINAL SYMPTOMS WITH LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION: RESULTS FROM A PHASE 3B TRIAL.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 287, doi. 10.1093/jcag/gwab002.235
- By:
- Publication type:
- Article
3
Anti-Inversion Rules, the Pfizer-Allergan Merger, and the U.S. Chamber of Commerce's Challenge.
- Published in:
- Review of Banking & Financial Law, 2016, v. 36, n. 1, p. 16
- By:
- Publication type:
- Article
4
PATENTLY UNJUST: TRIBAL SOVEREIGN IMMUNITY AT THE U.S. PATENT OFFICE.
- Published in:
- Southern California Law Review, 2019, v. 92, n. 3, p. 703
- By:
- Publication type:
- Article
5
product news.
- Published in:
- Ophthalmology Times Europe, 2015, v. 11, n. 7, p. 40
- Publication type:
- Article
6
Allergan receives FDA clearance for gel stent, a surgical treatment for refractory glaucoma.
- Published in:
- Ophthalmology Times Europe, 2016, v. 12, n. 10, p. 41
- Publication type:
- Article
7
ESCRS product launches.
- Published in:
- Ophthalmology Times Europe, 2015, v. 11, n. 10, p. 41
- Publication type:
- Article
8
Business digest.
- Published in:
- Chemistry & Industry, 2017, v. 81, n. 2, p. 12, doi. 10.1002/cind.812_3.x
- Publication type:
- Article
9
News.
- Published in:
- Chemistry & Industry, 2016, v. 80, n. 4, p. 5, doi. 10.1002/cind.804_3.x
- Publication type:
- Article
10
News.
- Published in:
- Chemistry & Industry, 2015, v. 79, n. 12, p. 6, doi. 10.1002/cind.7912_3.x
- Publication type:
- Article
11
The Business of Glaucoma Surgery and the Era of Mega-interest.
- Published in:
- Journal of Current Glaucoma Practice, 2016, v. 10, n. 2, p. iv
- By:
- Publication type:
- Article
12
Pfizer aborts Allergan deal.
- Published in:
- TCE: The Chemical Engineer, 2016, n. 899, p. 17
- Publication type:
- Article
13
Teva buying Allergan Generics for US$40.5bn.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 891, p. 8
- Publication type:
- Article
14
Vision Pan-America Editor's Choice Award 2015.
- Published in:
- Vision Pan-America, 2015, v. 14, n. 3, p. 84, doi. 10.15234/vpa.v14i3.299
- By:
- Publication type:
- Article
15
European Commission approves Amgen and Allergan's MVASI® (biosimilar bevacizumab) for the treatment of certain types of cancer.
- Published in:
- Oncolog-Hematolog, 2018, n. 42, p. 14
- Publication type:
- Article
16
MONETIZING TRIBAL AND STATE SOVEREIGN IMMUNITY IN PATENT LAW: AN ATTEMPT TO NEUTRALIZE THE PATENT DEATH SQUAD.
- Published in:
- Journal of Intellectual Property Law, 2019, v. 26, n. 1, p. 1
- By:
- Publication type:
- Article
17
The Filler Guide 2017.
- Published in:
- 2017
- By:
- Publication type:
- Product Review
18
Allergan launches initiative to fight preventable blindness.
- Published in:
- Optometry Times, 2017, v. 9, n. 3, p. 10
- Publication type:
- Article
19
Allergan gets FDA nod for Xen glaucoma gel stent.
- Published in:
- Optometry Times, 2016, v. 8, n. 12, p. 3
- Publication type:
- Article
20
Allergan acquires peri-ocular glaucoma ring technology.
- Published in:
- Optometry Times, 2016, v. 8, n. 9, p. 6
- Publication type:
- Article
21
Positive trial results for Oculeve Intranasal Tear Neurostimulator.
- Published in:
- Optometry Times, 2016, v. 8, n. 6, p. 22
- Publication type:
- Article
22
Allergan unveils Refresh Optive Gel Drops artifical fear.
- Published in:
- Optometry Times, 2015, v. 7, n. 11, p. 5
- Publication type:
- Article
23
Allergan recalls Refresh eye drops.
- Published in:
- Optometry Times, 2015, v. 7, n. 9, p. 32
- Publication type:
- Article
24
Treating dry eye with lipid-based eye drops.
- Published in:
- Optometry Times, 2015, v. 7, n. 9, p. 26
- By:
- Publication type:
- Article
25
Ethical drug updates.
- Published in:
- 2017
- Publication type:
- Product Review